These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 6887360)

  • 41. Accuracy of antibody-coated-bacteria test in recurrent urinary tract infections.
    Hawthorne NJ; Kurtz SB; Anhalt JP; Segura JW
    Mayo Clin Proc; 1978 Oct; 53(10):651-4. PubMed ID: 713596
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Ceftazidime, an open randomized comparison of 3 dosages for genitourinary infections.
    Childs SJ; Wells WG; Chubb JM
    J Urol; 1983 Sep; 130(3):495-7. PubMed ID: 6350616
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Clinical and bacteriological experience with the combined sulfonamide-pyridine derivative Uro Gantrisin in urinary tract infections].
    Jantsis A; Schmid W
    Med Welt; 1968 May; 18():1199-200. PubMed ID: 5705330
    [No Abstract]   [Full Text] [Related]  

  • 44. Trimethoprim-sulfamethoxazole for acute dysuria in women: a single-dose or 10-day course. A double-blind, randomized trial.
    Fihn SD; Johnson C; Roberts PL; Running K; Stamm WE
    Ann Intern Med; 1988 Mar; 108(3):350-7. PubMed ID: 3257670
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Antibody-coated bacteria in urine: criterion for a positive test and its value in defining a higher risk of treatment failure.
    Gargan RA; Brumfitt W; Hamilton-Miller JM
    Lancet; 1983 Sep; 2(8352):704-6. PubMed ID: 6136840
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Localization of catheter-induced urinary tract infections: interpretation of bladder washout and antibody-coated bacteria tests.
    Hulter HN; Borchardt KA; Mahood JA; Gelber RH; Kelso CL
    Nephron; 1984; 38(1):48-53. PubMed ID: 6382034
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A randomized comparison of 1-day versus 10-day antibacterial treatment of documented lower urinary tract infection.
    Pfau A; Sacks TG; Shapiro A; Shapiro M
    J Urol; 1984 Nov; 132(5):931-3. PubMed ID: 6387183
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Treatment of complicated urinary tract infection in adults: combined analysis of two randomized, double-blind, multicentre trials comparing ertapenem and ceftriaxone followed by appropriate oral therapy.
    Wells WG; Woods GL; Jiang Q; Gesser RM
    J Antimicrob Chemother; 2004 Jun; 53 Suppl 2():ii67-74. PubMed ID: 15150185
    [TBL] [Abstract][Full Text] [Related]  

  • 49. New directions in the diagnosis and therapy of urinary tract infections.
    Powers RD
    Am J Obstet Gynecol; 1991 May; 164(5 Pt 2):1387-9. PubMed ID: 2031519
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A clinical evaluation of a test for antibody-coated bacteria in the urine.
    Forsum U; Fritjofsson A; Frödin L; Hjelm E; Jonsell G
    Scand J Urol Nephrol; 1978; 12(1):45-8. PubMed ID: 565077
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Sulfonamide hepatitis. Report of a case due to sulfamethoxazole and sulfisoxazole.
    Fries J; Siragenian R
    N Engl J Med; 1966 Jan; 274(2):95-7. PubMed ID: 5901208
    [No Abstract]   [Full Text] [Related]  

  • 52. [Comparative study of intravenous ceftriaxone followed by oral cefixime versus ceftriaxone alone in the treatment of severe upper urinary tract infections].
    Regnier B
    Presse Med; 1989 Oct; 18(32):1617-21. PubMed ID: 2530546
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Antibody coated bacteria in urinary sediment during infections of urinary tract ].
    Horcicková M; Prát V; Matousovic K; Vítko S
    Cas Lek Cesk; 1982 Jul; 121(30):929-32. PubMed ID: 6749292
    [No Abstract]   [Full Text] [Related]  

  • 54. Antibody-coated bacteria in urine: when, where and why?
    Giamarellou H
    J Antimicrob Chemother; 1984 Feb; 13(2):95-9. PubMed ID: 6368519
    [No Abstract]   [Full Text] [Related]  

  • 55. Identification of site of urinary-tract infections by antibody-coated bacteria assay.
    Mundt KA; Polk BF
    Lancet; 1979 Dec; 2(8153):1172-5. PubMed ID: 91900
    [TBL] [Abstract][Full Text] [Related]  

  • 56. An open, non comparative study of ofloxacin i.v. on the treatment of acute symptomatic urinary tract infection.
    Asvanich K; Fugpholngam V; Srimuang S; Tanphaichitra D
    J Med Assoc Thai; 2000 Jul; 83(7):771-5. PubMed ID: 10932512
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Three-day treatment of urinary tract infections.
    Fair WR; Crane DB; Peterson LJ; Dahmer C; Tague B; Amos W
    J Urol; 1980 May; 123(5):717-21. PubMed ID: 7420563
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Outcomes of high-dose levofloxacin therapy remain bound to the levofloxacin minimum inhibitory concentration in complicated urinary tract infections.
    Armstrong ES; Mikulca JA; Cloutier DJ; Bliss CA; Steenbergen JN
    BMC Infect Dis; 2016 Nov; 16(1):710. PubMed ID: 27887579
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Sulfonamide-induced hemolytic anemia and hemoglobin Hasharon.
    Adams JG; Heller P; Abramson RK; Vaithianathan T
    Arch Intern Med; 1977 Oct; 137(10):1449-51. PubMed ID: 921425
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Constipation and urinary tract infection.
    Neumann PZ; DeDomenico IJ; Nogrady MB
    Pediatrics; 1973 Aug; 52(2):241-5. PubMed ID: 4578713
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.